Renaissance Capital logo


US IPO Week Ahead: IPO market starts with a quiet week as potential launches loom


Updated Monday, 4/1. The April IPO market is starting off with a fairly quiet calendar, with one large issuer scheduled for the week ahead. That could change, as several issuers are teed up for potential launches. Potential calendar additions include one larger recent filer, skilled nursing care provider PACS Group (PACS). A few other sizable IPOs more

US IPO Week Ahead: Several IPOs in the pipeline are primed for post-Thanksgiving launches


With the Thanksgiving holiday behind us, the IPO market is officially entering the final stretch of 2023. Many candidates have indicated plans to wait until 2024, but rumbles in the pipeline mean that we could still see some activity before year-end. Several issuers are primed for post-Thanksgiving launches. Recent filers like product testing company UL more

US IPO Week Ahead: IPO market breaks for the Thanksgiving holiday


The IPO calendar looks quiet for the Thanksgiving week, although some small issuers may join last minute. While there are no deals currently scheduled, rumbles in the pipeline mean that we could see some activity in December. Potential post-Thanksgiving launches include recent filers like product testing company UL Solutions (ULS), Chinese EV more

US IPO Weekly Recap: Smaller deals slip through the IPO window before the Thanksgiving break


Four smaller IPOs priced this past week, joined by one SPAC. The biggest news came from the pipeline, with product assessment services provider UL Solutions (ULS) filing for an estimated $1 billion IPO, followed by a sizable filing from metabolic disease biotech Carmot Therapeutics (CRMO). Other large issuers on file provided updates ahead more